Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-04-30 Option Award |
2020-05-04 7:40 pm |
N/A 2030-04-30 |
INNOVATE BIOPHARMACEUTICALS INC. | NMTR | Darvish Nissim Director 10% Owner |
50,000 | $0 | 50,000 (Indirect) |
View |
Ownership |
2020-05-04 7:39 pm |
N/A N/A |
INNOVATE BIOPHARMACEUTICALS INC. | NMTR | Darvish Nissim Director 10% Owner |
0 | $0 | 16,986,521 (Indirect) |
View |
| 2020-04-30 Option Award |
2020-05-04 7:21 pm |
N/A 2030-04-30 |
INNOVATE BIOPHARMACEUTICALS INC. | NMTR | OrbiMed Israel GP Ltd. OrbiMed Israel BioFund GP Limited Partnership Director 10% Owner |
50,000 | $0 | 50,000 (Indirect) |
View |
| 2020-04-30 Option Award |
2020-05-04 7:18 pm |
N/A 2030-04-30 |
INNOVATE BIOPHARMACEUTICALS INC. | NMTR | Sirgo Mark A Director |
50,000 | $0 | 50,000 (Direct) |
View |
Ownership |
2020-05-04 7:15 pm |
N/A N/A |
INNOVATE BIOPHARMACEUTICALS INC. | NMTR | OrbiMed Israel GP Ltd. OrbiMed Israel BioFund GP Limited Partnership Director 10% Owner |
0 | $0 | 16,986,521 (Indirect) |
View |
| 2020-04-30 Option Award |
2020-05-04 7:09 pm |
N/A 2030-04-30 |
INNOVATE BIOPHARMACEUTICALS INC. | NMTR | Temperato John Chief Executive Officer |
1,000,000 | $0 | 1,000,000 (Direct) |
View |
Ownership |
2020-05-04 7:00 pm |
N/A N/A |
INNOVATE BIOPHARMACEUTICALS INC. | NMTR | Sirgo Mark A Director |
0 | $0 | 286,184 (Direct) |
View |
Ownership |
2020-05-04 6:58 pm |
N/A N/A |
INNOVATE BIOPHARMACEUTICALS INC. | NMTR | Temperato John Chief Executive Officer |
0 | $0 | 286,184 (Direct) |
View |
| 2020-04-24 Option Award |
2020-05-04 6:12 pm |
2020-04-24 2030-04-24 |
INNOVATE BIOPHARMACEUTICALS INC. | NMTR | Proujansky Roy Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-04-24 Option Award |
2020-05-04 6:04 pm |
2020-04-24 2030-04-24 |
INNOVATE BIOPHARMACEUTICALS INC. | NMTR | JOHNSON LORIN K Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-04-24 Option Award |
2020-05-04 6:02 pm |
2020-04-24 2030-04-24 |
INNOVATE BIOPHARMACEUTICALS INC. | NMTR | Laumas Sandeep Director |
389,294 | $0 | 389,294 (Direct) |
View |
| 2020-04-24 Option Award |
2020-05-04 5:59 pm |
2020-04-24 2030-04-24 |
INNOVATE BIOPHARMACEUTICALS INC. | NMTR | Sitar Edward J Chief Financial Officer |
301,156 | $0 | 301,156 (Direct) |
View |
| 2020-04-24 Option Award |
2020-05-04 5:55 pm |
2020-04-24 2030-04-24 |
INNOVATE BIOPHARMACEUTICALS INC. | NMTR | MAIDA ANTHONY E III Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-04-24 Option Award |
2020-05-04 5:54 pm |
2020-04-24 2030-04-24 |
INNOVATE BIOPHARMACEUTICALS INC. | NMTR | Ramasastry Saira Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-04-24 Option Award |
2020-05-04 5:53 pm |
2020-04-24 2030-04-24 |
INNOVATE BIOPHARMACEUTICALS INC. | NMTR | Madan Jay P. President |
203,406 | $0 | 203,406 (Direct) |
View |